These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36526090)

  • 1. TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy.
    Rubio T; Viana R; Moreno-Estellés M; Campos-Rodríguez Á; Sanz P
    Neurobiol Dis; 2023 Jan; 176():105964. PubMed ID: 36526090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age.
    Lahuerta M; Gonzalez D; Aguado C; Fathinajafabadi A; García-Giménez JL; Moreno-Estellés M; Romá-Mateo C; Knecht E; Pallardó FV; Sanz P
    Mol Neurobiol; 2020 Mar; 57(3):1607-1621. PubMed ID: 31808062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial Effect of Fingolimod in a Lafora Disease Mouse Model by Preventing Reactive Astrogliosis-Derived Neuroinflammation and Brain Infiltration of T-lymphocytes.
    Rubio T; Campos-Rodríguez Á; Sanz P
    Mol Neurobiol; 2024 Jun; 61(6):3105-3120. PubMed ID: 37971656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model.
    Mollá B; Heredia M; Campos Á; Sanz P
    Mol Neurobiol; 2022 Oct; 59(10):6018-6032. PubMed ID: 35835895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
    Nitschke S; Sullivan MA; Mitra S; Marchioni CR; Lee JPY; Smith BH; Ahonen S; Wu J; Chown EE; Wang P; Petković S; Zhao X; DiGiovanni LF; Perri AM; Israelian L; Grossman TR; Kordasiewicz H; Vilaplana F; Iwai K; Nitschke F; Minassian BA
    Brain; 2022 Jul; 145(7):2361-2377. PubMed ID: 35084461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype variations in Lafora progressive myoclonus epilepsy: possible involvement of genetic modifiers?
    Singh S; Ganesh S
    J Hum Genet; 2012 May; 57(5):283-5. PubMed ID: 22456482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.
    Sullivan MA; Nitschke S; Steup M; Minassian BA; Nitschke F
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type.
    Rubio-Villena C; Viana R; Bonet J; Garcia-Gimeno MA; Casado M; Heredia M; Sanz P
    Hum Mol Genet; 2018 Apr; 27(7):1290-1300. PubMed ID: 29408991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress.
    Sinha P; Verma B; Ganesh S
    Mol Neurobiol; 2021 Mar; 58(3):1088-1101. PubMed ID: 33094475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lafora disease.
    Turnbull J; Tiberia E; Striano P; Genton P; Carpenter S; Ackerley CA; Minassian BA
    Epileptic Disord; 2016 Sep; 18(S2):38-62. PubMed ID: 27702709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.
    Nitschke S; Chown EE; Zhao X; Gabrielian S; Petković S; Guisso DR; Perri AM; Wang P; Ahonen S; Nitschke F; Minassian BA
    J Biol Chem; 2021; 296():100150. PubMed ID: 33277363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.
    Spuch C; Ortolano S; Navarro C
    Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models.
    López-González I; Viana R; Sanz P; Ferrer I
    Mol Neurobiol; 2017 Jul; 54(5):3119-3130. PubMed ID: 27041370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Related microRNA Overexpression in Lafora Disease Male Mice Provides Links between Neuroinflammation and Oxidative Stress.
    Romá-Mateo C; Lorente-Pozo S; Márquez-Thibaut L; Moreno-Estellés M; Garcés C; González D; Lahuerta M; Aguado C; García-Giménez JL; Sanz P; Pallardó FV
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinic.
    Gentry MS; Afawi Z; Armstrong DD; Delgado-Escueta A; Goldberg YP; Grossman TR; Guinovart JJ; Harris F; Hurley TD; Michelucci R; Minassian BA; Sanz P; Worby CA; Serratosa JM
    Epilepsy Behav; 2020 Feb; 103(Pt A):106839. PubMed ID: 31932179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epm2a
    Burgos DF; Sciaccaluga M; Worby CA; Zafra-Puerta L; Iglesias-Cabeza N; Sánchez-Martín G; Prontera P; Costa C; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2023 Jun; 181():106119. PubMed ID: 37059210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel compound heterozygous EPM2A mutation in a Chinese boy with Lafora disease.
    Fu Y; Zhou C; Song R; Peng J; Yang X; Xiao B; Zhou J; Long H
    Neurol Sci; 2020 Aug; 41(8):2267-2270. PubMed ID: 32342326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset Lafora body disease.
    Turnbull J; Girard JM; Lohi H; Chan EM; Wang P; Tiberia E; Omer S; Ahmed M; Bennett C; Chakrabarty A; Tyagi A; Liu Y; Pencea N; Zhao X; Scherer SW; Ackerley CA; Minassian BA
    Brain; 2012 Sep; 135(Pt 9):2684-98. PubMed ID: 22961547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with metformin in twelve patients with Lafora disease.
    Bisulli F; Muccioli L; d'Orsi G; Canafoglia L; Freri E; Licchetta L; Mostacci B; Riguzzi P; Pondrelli F; Avolio C; Martino T; Michelucci R; Tinuper P
    Orphanet J Rare Dis; 2019 Jun; 14(1):149. PubMed ID: 31227012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.